356 related articles for article (PubMed ID: 34638264)
1. Steroid Receptors in Breast Cancer: Understanding of Molecular Function as a Basis for Effective Therapy Development.
Kowalczyk W; Waliszczak G; Jach R; Dulińska-Litewka J
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638264
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide crosstalk between steroid receptors in breast and prostate cancers.
Paakinaho V; Palvimo JJ
Endocr Relat Cancer; 2021 Jul; 28(9):R231-R250. PubMed ID: 34137734
[TBL] [Abstract][Full Text] [Related]
3. Dissection of androgen receptor-promoter interactions: steroid receptors partition their interaction energetics in parallel with their phylogenetic divergence.
De Angelis RW; Yang Q; Miura MT; Bain DL
J Mol Biol; 2013 Nov; 425(22):4223-35. PubMed ID: 23917122
[TBL] [Abstract][Full Text] [Related]
4. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
5. The multifaceted role of the mineralocorticoid receptor in cancers.
Doan TB; Graham JD
J Steroid Biochem Mol Biol; 2024 Sep; 242():106541. PubMed ID: 38714226
[TBL] [Abstract][Full Text] [Related]
6. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
7. 90 YEARS OF PROGESTERONE: Steroid receptors as MAPK signaling sensors in breast cancer: let the fates decide.
Dwyer AR; Truong TH; Ostrander JH; Lange CA
J Mol Endocrinol; 2020 Jul; 65(1):T35-T48. PubMed ID: 32209723
[TBL] [Abstract][Full Text] [Related]
8. Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels.
Hall RE; Lee CS; Alexander IE; Shine J; Clarke CL; Sutherland RL
Int J Cancer; 1990 Dec; 46(6):1081-7. PubMed ID: 2249895
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
[TBL] [Abstract][Full Text] [Related]
10. Family Matters: Collaboration and Conflict Among the Steroid Receptors Raises a Need for Group Therapy.
Sikora MJ
Endocrinology; 2016 Dec; 157(12):4553-4560. PubMed ID: 27835038
[TBL] [Abstract][Full Text] [Related]
11. Hormone receptors in breast cancer: more than estrogen receptors.
Lamb CA; Vanzulli SI; Lanari C
Medicina (B Aires); 2019; 79(Spec 6/1):540-545. PubMed ID: 31864223
[TBL] [Abstract][Full Text] [Related]
12. Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers.
Truong TH; Lange CA
Endocrinology; 2018 Dec; 159(12):3897-3907. PubMed ID: 30307542
[TBL] [Abstract][Full Text] [Related]
13. Non-genomic signaling of steroid receptors in cancer.
Thiebaut C; Vlaeminck-Guillem V; Trédan O; Poulard C; Le Romancer M
Mol Cell Endocrinol; 2021 Dec; 538():111453. PubMed ID: 34520815
[TBL] [Abstract][Full Text] [Related]
14. Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.
Leehy KA; Regan Anderson TM; Daniel AR; Lange CA; Ostrander JH
J Mol Endocrinol; 2016 Apr; 56(3):R99-R114. PubMed ID: 26831511
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays.
Fuhrmann U; Slater EP; Fritzemeier KH
Contraception; 1995 Jan; 51(1):45-52. PubMed ID: 7750284
[TBL] [Abstract][Full Text] [Related]
16. Nuclear tristetraprolin acts as a corepressor of multiple steroid nuclear receptors in breast cancer cells.
Barrios-García T; Gómez-Romero V; Tecalco-Cruz Á; Valadéz-Graham V; León-Del-Río A
Mol Genet Metab Rep; 2016 Jun; 7():20-6. PubMed ID: 27114912
[TBL] [Abstract][Full Text] [Related]
17. Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic.
Kumar S; Freelander A; Lim E
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638457
[TBL] [Abstract][Full Text] [Related]
18. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
19. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC; Warren R
Cancer Res; 1979 Jun; 39(6 Pt 1):1973-9. PubMed ID: 445396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
